<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00654745</url>
  </required_header>
  <id_info>
    <org_study_id>CS-8663-403</org_study_id>
    <nct_id>NCT00654745</nct_id>
  </id_info>
  <brief_title>18 Week Study Evaluating Safety and Efficacy of Olmesartan, Amlodipine, and Hydrochlorothiazide, in Type 2 Diabetics</brief_title>
  <official_title>A Prospective, Open-label, Ambulatory Blood Pressure Monitoring (ABPM) Dose Titration Study to Evaluate the Safety and Efficacy of an Olmesartan Medoxomil and Amlodipine Based Treatment Regimen in Hypertensive, Type 2 Diabetic Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Daiichi Sankyo, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Daiichi Sankyo, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine if olmesartan plus amlodipine combination therapy alone and with
      hydrochlorothiazide will be safe and effective to reduce high blood pressure in hypertensive,
      type 2 diabetic subjects.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a single group study in which participants were titrated to the next of 6 regimens if
      blood pressure (BP) goals were not met.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2008</start_date>
  <completion_date type="Actual">June 2009</completion_date>
  <primary_completion_date type="Actual">April 2009</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change From Week 0 (Baseline) in Mean 24-hour Ambulatory Blood Pressure Monitoring (ABPM) Systolic Blood Pressure (SBP) After 12 Weeks of Active Treatment</measure>
    <time_frame>week 0 - week 12</time_frame>
    <description>Change from week 0 (baseline) in mean 24-hour Ambulatory Blood Pressure Monitoring (ABPM) Systolic Blood Pressure (SBP) after 12 weeks of active treatment. change = week 12 - week 0.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change From Week 0 (Baseline) in Mean ABPM Diastolic Blood Pressure (DBP) After 12 Weeks of Active Treatment</measure>
    <time_frame>week 0 - week 12 (24-hour, Daytime, Nighttime, Last 6 hour, Last 4 hour, Last 2 hour)</time_frame>
    <description>24-hour mean DBP, Daytime mean DBP, Nighttime mean DBP, Last 6 hour mean DBP, Last 4 hour mean DBP, Last 2 hour mean DBP</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Week 0 (Baseline) in Mean ABPM SBP After 12 Weeks of Active Treatment</measure>
    <time_frame>week 0 - week 12 (24-hour, Daytime, Nighttime, Last 6 hour, Last 4 hour, Last 2 hour)</time_frame>
    <description>Daytime mean SBP, Nighttime mean SBP, Last 6 hour mean SBP, Last 4 hour mean SBP, Last 2 hour mean SBP</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Mean Seated Systolic Blood Pressure (SeSBP) From Week 0 (Baseline) After 3, 6, 9, 12, 15, and 18 Weeks</measure>
    <time_frame>week 0 - weeks 3, 6, 9, 12, 15, 18</time_frame>
    <description>change in mean SeSBP from week 0 (baseline) to Weeks 3, 6, 9, 12, 15, and 18.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Mean Seated Diastolic Blood Pressure (SeDBP) From Week 0 (Baseline) After 3, 6, 9, 12, 15, and 18 Weeks</measure>
    <time_frame>week 0 - weeks 3, 6, 9, 12, 15, 18</time_frame>
    <description>change in mean SeDBP from week 0 (baseline) to Weeks 3, 6, 9, 12, 15, and 18.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Achieving Mean 24-hour Ambulatory Blood Pressure Thresholds at Week 12</measure>
    <time_frame>week 0 - week 12</time_frame>
    <description>number of participants achieving mean 24-hour ambulatory blood pressure thresholds BP&lt;135/85, BP&lt;130/80, BP&lt;125/75, BP&lt;120/80, SBP&lt;135, SBP&lt;130, SBP&lt;125, SBP&lt;120, DBP&lt;85, DBP&lt;80, DBP&lt;75 at week 12</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Achieving Mean Daytime Ambulatory Blood Pressure Thresholds at Week 12</measure>
    <time_frame>week 0 - week 12</time_frame>
    <description>number of participants achieving mean daytime ambulatory blood pressure thresholds BP&lt;135/85, BP&lt;130/80, BP&lt;125/75, BP&lt;120/80, SBP&lt;135, SBP&lt;130, SBP&lt;125, SBP&lt;120, DBP&lt;85, DBP&lt;80, DBP&lt;75 at week 12</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Achieving Mean Nighttime Ambulatory Blood Pressure Thresholds at Week 12</measure>
    <time_frame>week 0 - week 12</time_frame>
    <description>number of participants achieving mean nighttime ambulatory blood pressure thresholds BP&lt;135/85, BP&lt;130/80, BP&lt;125/75, BP&lt;120/80, BP&lt;120/70, SBP&lt;135, SBP&lt;130, SBP&lt;125, SBP&lt;120, DBP&lt;85, DBP&lt;80, DBP&lt;75, DBP&lt;70 at week 12</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Achieving Mean Last 6 Hour Ambulatory Blood Pressure Thresholds at Week 12</measure>
    <time_frame>week 0 - week 12</time_frame>
    <description>number participants achieving mean last 6 hour ambulatory blood pressure thresholds BP&lt;135/85, BP&lt;130/80, BP&lt;125/75, BP&lt;120/80, SBP&lt;135, SBP&lt;130, SBP&lt;125, SBP&lt;120, DBP&lt;85, DBP&lt;80, DBP&lt;75 at week 12</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Achieving Mean Last 4 Hour Ambulatory Blood Pressure Thresholds at Week 12</measure>
    <time_frame>week 0 - week 12</time_frame>
    <description>number of participants achieving mean last 4 hour ambulatory blood pressure thresholds BP&lt;135/85, BP&lt;130/80, BP&lt;125/75, BP&lt;120/80, SBP&lt;135, SBP&lt;130, SBP&lt;125, SBP&lt;120, DBP&lt;85, DBP&lt;80, DBP&lt;75 at week 12</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Achieving Mean Last 2 Hour Ambulatory Blood Pressure Thresholds at Week 12</measure>
    <time_frame>week 0 - week 12</time_frame>
    <description>number of participants achieving mean last 2 hour ambulatory blood pressure thresholds BP&lt;135/85, BP&lt;130/80, BP&lt;125/75, BP&lt;120/80, SBP&lt;135, SBP&lt;130, SBP&lt;125, SBP&lt;120, DBP&lt;85, DBP&lt;80, DBP&lt;75 at week 12</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Achieving Seated Systolic and Diastolic Blood Pressure Thresholds at Week 3</measure>
    <time_frame>week 0 - week 3</time_frame>
    <description>number of participants achieving seated systolic and diastolic blood pressure thresholds BP&lt;135/85, BP&lt;130/80, BP&lt;125/75, BP&lt;120/80, SBP&lt;135, SBP&lt;130, SBP&lt;125, SBP&lt;120, DBP&lt;85, DBP&lt;80, DBP&lt;75 at week 3</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Achieving Seated Systolic and Diastolic Blood Pressure Thresholds at Week 6</measure>
    <time_frame>week 0 - week 6</time_frame>
    <description>number of participants achieving seated systolic and diastolic blood pressure thresholds BP&lt;135/85, BP&lt;130/80, BP&lt;125/75, BP&lt;120/80, SBP&lt;135, SBP&lt;130, SBP&lt;125, SBP&lt;120, DBP&lt;85, DBP&lt;80, DBP&lt;75 at week 6</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Achieving Seated Systolic and Diastolic Blood Pressure Thresholds at Week 9</measure>
    <time_frame>week 0 - week 9</time_frame>
    <description>number of participants achieving seated systolic and diastolic blood pressure thresholds BP&lt;135/85, BP&lt;130/80, BP&lt;125/75, BP&lt;120/80, SBP&lt;135, SBP&lt;130, SBP&lt;125, SBP&lt;120, DBP&lt;85, DBP&lt;80, DBP&lt;75 at week 9</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Achieving Seated Systolic and Diastolic Blood Pressure Thresholds at Week 12</measure>
    <time_frame>week 0 - week 12</time_frame>
    <description>number of participants achieving seated systolic and diastolic blood pressure thresholds BP&lt;135/85, BP&lt;130/80, BP&lt;125/75, BP&lt;120/80, SBP&lt;135, SBP&lt;130, SBP&lt;125, SBP&lt;120, DBP&lt;85, DBP&lt;80, DBP&lt;75 at week 12</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Achieving Seated Systolic and Diastolic Blood Pressure Thresholds at Week 15</measure>
    <time_frame>week 0 - week 15</time_frame>
    <description>number of participants achieving seated systolic and diastolic blood pressure thresholds BP&lt;135/85, BP&lt;130/80, BP&lt;125/75, BP&lt;120/80, SBP&lt;135, SBP&lt;130, SBP&lt;125, SBP&lt;120, DBP&lt;85, DBP&lt;80, DBP&lt;75 at week 15</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Achieving Seated Systolic and Diastolic Blood Pressure Thresholds at Week 18</measure>
    <time_frame>week 0 - week 18</time_frame>
    <description>number of participants achieving seated systolic and diastolic blood pressure thresholds BP&lt;135/85, BP&lt;130/80, BP&lt;125/75, BP&lt;120/80, SBP&lt;135, SBP&lt;130, SBP&lt;125, SBP&lt;120, DBP&lt;85, DBP&lt;80, DBP&lt;75 at week 18</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Achieving Mean 24 Hour Ambulatory Systolic and Diastolic Blood Pressure Reductions at Week 12</measure>
    <time_frame>week 0 - week 12</time_frame>
    <description>number of participants achieving mean 24 hour ambulatory systolic and diastolic blood pressure reductions of; SBP reduction &lt;= 15 mmHg, SBP reduction &gt; 15 mmHg &amp; &lt;= 30 mmHg, SBP reduction &gt; 30 mmHg &amp; &lt;= 45 mmHg, SBP reduction &gt; 45 mmHg, DBP reduction &lt;= 10 mmHg, DBP reduction &gt; 10 mmHg &amp; &lt;= 15 mmHg, DBP reduction &gt; 15 mmHg &amp; &lt;= 20 mmHg, DBP reduction &gt; 20 mmHg at week 12</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Achieving Mean Daytime Ambulatory Systolic and Diastolic Blood Pressure Reductions at Week 12</measure>
    <time_frame>week 0 - week 12</time_frame>
    <description>number of participants achieving mean daytime ambulatory systolic and diastolic blood pressure reductions of; SBP reduction &lt;= 15 mmHg, SBP reduction &gt; 15 mmHg &amp; &lt;= 30 mmHg, SBP reduction &gt; 30 mmHg &amp; &lt;= 45 mmHg, SBP reduction &gt; 45 mmHg, DBP reduction &lt;= 10 mmHg, DBP reduction &gt; 10 mmHg &amp; &lt;= 15 mmHg, DBP reduction &gt; 15 mmHg &amp; &lt;= 20 mmHg, DBP reduction &gt; 20 mmHg at week 12</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Achieving Mean Nighttime Ambulatory Systolic and Diastolic Blood Pressure Reductions at Week 12</measure>
    <time_frame>week 0 - week 12</time_frame>
    <description>number of participants achieving mean nighttime ambulatory systolic and diastolic blood pressure reductions of; SBP reduction &lt;= 15 mmHg, SBP reduction &gt; 15 mmHg &amp; &lt;= 30 mmHg, SBP reduction &gt; 30 mmHg &amp; &lt;= 45 mmHg, SBP reduction &gt; 45 mmHg, DBP reduction &lt;= 10 mmHg, DBP reduction &gt; 10 mmHg &amp; &lt;= 15 mmHg, DBP reduction &gt; 15 mmHg &amp; &lt;= 20 mmHg, DBP reduction &gt; 20 mmHg at week 12</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Achieving Mean Last 6 Hour Ambulatory Systolic and Diastolic Blood Pressure Reductions at Week 12</measure>
    <time_frame>week 0 - week 12</time_frame>
    <description>number of participants achieving mean last 6 hour ambulatory systolic and diastolic blood pressure reductions of; SBP reduction &lt;= 15 mmHg, SBP reduction &gt; 15 mmHg &amp; &lt;= 30 mmHg, SBP reduction &gt; 30 mmHg &amp; &lt;= 45 mmHg, SBP reduction &gt; 45 mmHg, DBP reduction &lt;= 10 mmHg, DBP reduction &gt; 10 mmHg &amp; &lt;= 15 mmHg, DBP reduction &gt; 15 mmHg &amp; &lt;= 20 mmHg, DBP reduction &gt; 20 mmHg at week 12</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Achieving Mean Last 4 Hour Ambulatory Systolic and Diastolic Blood Pressure Reductions</measure>
    <time_frame>week 0 - week 12</time_frame>
    <description>number of participants achieving mean last 4 hour ambulatory systolic and diastolic blood pressure reductions of; SBP reduction &lt;= 15 mmHg, SBP reduction &gt; 15 mmHg &amp; &lt;= 30 mmHg, SBP reduction &gt; 30 mmHg &amp; &lt;= 45 mmHg, SBP reduction &gt; 45 mmHg, DBP reduction &lt;= 10 mmHg, DBP reduction &gt; 10 mmHg &amp; &lt;= 15 mmHg, DBP reduction &gt; 15 mmHg &amp; &lt;= 20 mmHg, DBP reduction &gt; 20 mmHg at week 12</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Achieving Mean Last 2 Hour Ambulatory Systolic and Diastolic Blood Pressure Reductions at Week 12</measure>
    <time_frame>week 0 - week 12</time_frame>
    <description>number of participants achieving mean last 2 hour ambulatory systolic and diastolic blood pressure reductions of; SBP reduction &lt;= 15 mmHg, SBP reduction &gt; 15 mmHg &amp; &lt;= 30 mmHg, SBP reduction &gt; 30 mmHg &amp; &lt;= 45 mmHg, SBP reduction &gt; 45 mmHg, DBP reduction &lt;= 10 mmHg, DBP reduction &gt; 10 mmHg &amp; &lt;= 15 mmHg, DBP reduction &gt; 15 mmHg &amp; &lt;= 20 mmHg, DBP reduction &gt; 20 mmHg at week 12</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Achieving Mean Seated Systolic and Diastolic Blood Pressure Reductions at Week 3</measure>
    <time_frame>week 0 - week 3</time_frame>
    <description>number of participants achieving mean seated systolic and diastolic blood pressure reductions of; SBP reduction &lt;= 15 mmHg, SBP reduction &gt; 15 mmHg &amp; &lt;= 30 mmHg, SBP reduction &gt; 30 mmHg &amp; &lt;= 45 mmHg, SBP reduction &gt; 45 mmHg, DBP reduction &lt;= 10 mmHg, DBP reduction &gt; 10 mmHg &amp; &lt;= 15 mmHg, DBP reduction &gt; 15 mmHg &amp; &lt;= 20 mmHg, DBP reduction &gt; 20 mmHg at week 3</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Achieving Mean Seated Systolic and Diastolic Blood Pressure Reductions at Week 6</measure>
    <time_frame>week 0 - week 6</time_frame>
    <description>number of participants achieving mean seated systolic and diastolic blood pressure reductions of; SBP reduction &lt;= 15 mmHg, SBP reduction &gt; 15 mmHg &amp; &lt;= 30 mmHg, SBP reduction &gt; 30 mmHg &amp; &lt;= 45 mmHg, SBP reduction &gt; 45 mmHg, DBP reduction &lt;= 10 mmHg, DBP reduction &gt; 10 mmHg &amp; &lt;= 15 mmHg, DBP reduction &gt; 15 mmHg &amp; &lt;= 20 mmHg, DBP reduction &gt; 20 mmHg at week 6</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Achieving Mean Seated Systolic and Diastolic Blood Pressure Reductions at Week 9</measure>
    <time_frame>week 0 - week 9</time_frame>
    <description>number of participants achieving mean seated systolic and diastolic blood pressure reductions of; SBP reduction &lt;= 15 mmHg, SBP reduction &gt; 15 mmHg &amp; &lt;= 30 mmHg, SBP reduction &gt; 30 mmHg &amp; &lt;= 45 mmHg, SBP reduction &gt; 45 mmHg, DBP reduction &lt;= 10 mmHg, DBP reduction &gt; 10 mmHg &amp; &lt;= 15 mmHg, DBP reduction &gt; 15 mmHg &amp; &lt;= 20 mmHg, DBP reduction &gt; 20 mmHg at week 9</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Achieving Mean Seated Systolic and Diastolic Blood Pressure Reductions at Week 12</measure>
    <time_frame>week 0 - week 12</time_frame>
    <description>number of participants achieving mean seated systolic and diastolic blood pressure reductions of; SBP reduction &lt;= 15 mmHg, SBP reduction &gt; 15 mmHg &amp; &lt;= 30 mmHg, SBP reduction &gt; 30 mmHg &amp; &lt;= 45 mmHg, SBP reduction &gt; 45 mmHg, DBP reduction &lt;= 10 mmHg, DBP reduction &gt; 10 mmHg &amp; &lt;= 15 mmHg, DBP reduction &gt; 15 mmHg &amp; &lt;= 20 mmHg, DBP reduction &gt; 20 mmHg at week 12</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Achieving Mean Seated Systolic and Diastolic Blood Pressure Reductions at Week 15</measure>
    <time_frame>week 0 - week 15</time_frame>
    <description>number of participants achieving mean seated systolic and diastolic blood pressure reductions of; SBP reduction &lt;= 15 mmHg, SBP reduction &gt; 15 mmHg &amp; &lt;= 30 mmHg, SBP reduction &gt; 30 mmHg &amp; &lt;= 45 mmHg, SBP reduction &gt; 45 mmHg, DBP reduction &lt;= 10 mmHg, DBP reduction &gt; 10 mmHg &amp; &lt;= 15 mmHg, DBP reduction &gt; 15 mmHg &amp; &lt;= 20 mmHg, DBP reduction &gt; 20 mmHg at week 15</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Achieving Mean Seated Systolic and Diastolic Blood Pressure Reductions at Week 18</measure>
    <time_frame>week 0 - week 18</time_frame>
    <description>number of participants achieving mean seated systolic and diastolic blood pressure reductions of; SBP reduction &lt;= 15 mmHg, SBP reduction &gt; 15 mmHg &amp; &lt;= 30 mmHg, SBP reduction &gt; 30 mmHg &amp; &lt;= 45 mmHg, SBP reduction &gt; 45 mmHg, DBP reduction &lt;= 10 mmHg, DBP reduction &gt; 10 mmHg &amp; &lt;= 15 mmHg, DBP reduction &gt; 15 mmHg &amp; &lt;= 20 mmHg, DBP reduction &gt; 20 mmHg at week 18</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">207</enrollment>
  <condition>Type 2 Diabetes</condition>
  <condition>Hypertension</condition>
  <arm_group>
    <arm_group_label>aml + olm + hctz</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>amlodipine; and olmesartan medoxomil, if required; and hydrochlorothiazide, if required.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Amlodipine</intervention_name>
    <description>Amlodipine 5 mg tablets , Daily for 3 weeks;</description>
    <arm_group_label>aml + olm + hctz</arm_group_label>
    <other_name>Norvasc</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>amlodipine / olmesartan medoxomil combination</intervention_name>
    <description>amlodipine / olmesartan medoxomil combination tablets 5 mg/20 mg or 5 mg/40 mg or 10 mg/40 mg</description>
    <arm_group_label>aml + olm + hctz</arm_group_label>
    <other_name>Azor</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hydrochlorothiazide</intervention_name>
    <description>hydrochlorothiazide tablets, 12.5 mg or 25 mg.</description>
    <arm_group_label>aml + olm + hctz</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Males or females aged 18 to 80 years.

          -  Diagnosis of type 2 diabetes mellitus and on a stable regimen of any oral antidiabetic
             agent(s) for at least 3 months, with or without adjunctive use of Byetta (exenatide);

        Note: Subjects diagnosed with type 2 diabetes mellitus who were not on oral antidiabetic
        agents may have been enrolled if they had a documented history of type 2 diabetes by
        American Diabetes Association criteria, including the specific plasma glucose results
        listed below:

          -  Fasting plasma glucose &gt;=126 mg/dL (7.0 mmol/L); or

          -  Symptoms of hyperglycemia and a casual (any time of day without regard to time since
             last meal) plasma glucose &gt;=200 mg/dL (11.1 mmol/L). The classic symptoms of
             hyperglycemia were considered to include polyuria, polydipsia, and unexplained weight
             loss; or

          -  Two-hour plasma glucose &gt;=200 mg/dL (11.1 mmol/L) during an oral glucose tolerance
             test;

          -  Newly diagnosed hypertension or uncontrolled hypertension (defined as SBP &gt;130 mmHg
             and/or DBP &gt;80 mmHg) on current antihypertensive monotherapy or combination therapy.

          -  Subjects must fulfill mean seated office blood pressure parameters at two consecutive,
             qualifying visits during the placebo run-in phase, and, subsequently, daytime
             ambulatory blood pressure monitoring (ABPM) criteria.

          -  Females should not be pregnant or lactating and, if applicable, using adequate
             contraception.

        Exclusion Criteria:

          -  Subjects with uncontrolled hypertension taking multiple antihypertensive therapies (at
             the discretion of the investigator).

          -  Type 2 diabetes mellitus with a glycosylated hemoglobin A1c (HbA1c) &gt;=9.0% at
             screening;

          -  Subjects with type 1 or type 2 diabetes mellitus requiring insulin.

          -  Subjects with any serious disorder which may limit the ability to evaluate the safety
             and efficacy of study medication, or subjects with secondary hypertension.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sylmar</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Tustin</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Aventura</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>DeLand</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Hialeah</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Pembroke Pines</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Avon</city>
        <state>Indiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>New Windsor</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Greer</city>
        <state>South Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Taylors</city>
        <state>South Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Burke</city>
        <state>Virginia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 4, 2008</study_first_submitted>
  <study_first_submitted_qc>April 8, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 9, 2008</study_first_posted>
  <results_first_submitted>April 21, 2010</results_first_submitted>
  <results_first_submitted_qc>May 26, 2010</results_first_submitted_qc>
  <results_first_posted type="Estimate">July 2, 2010</results_first_posted>
  <last_update_submitted>July 9, 2010</last_update_submitted>
  <last_update_submitted_qc>July 9, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 13, 2010</last_update_posted>
  <responsible_party>
    <name_title>Director, Medical Research, Hypertension</name_title>
    <organization>Daiichi Sankyo Inc.</organization>
  </responsible_party>
  <keyword>blood pressure reduction</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Olmesartan</mesh_term>
    <mesh_term>Amlodipine</mesh_term>
    <mesh_term>Hydrochlorothiazide</mesh_term>
    <mesh_term>Olmesartan Medoxomil</mesh_term>
    <mesh_term>Amlodipine Besylate, Olmesartan Medoxomil Drug Combination</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Subjects were recruited at 32 sites in the USA from May 12, 2008 to Jan 2, 2009 and 207 enrolled into the active treatment period. The study population consisted of subjects with controlled type 2 diabetes, not requiring insulin therapy, whose hypertension was newly diagnosed or uncontrolled on antihypertensive monotherapy or combination therapy.</recruitment_details>
      <pre_assignment_details>Subjects began washout of anti-hypertensive medications during screening then entered placebo run-in lasting 2-3 weeks. Subjects must meet seated blood pressure (BP) criteria at 2 consecutive qualifying visits during the run-in period and satisfy mean daytime ambulatory BP criteria at baseline, one day prior to the first dose of active study drug.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Amlodipine, Olmesartan Medoxomil, Hydrochlorothiazide</title>
          <description>Participants receiving amlodipine + olmesartan medoxomil, if required, + hydrochlorothiazide, if required</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="207">This is single group study in which subjects were titrated to the next of 7 arms if BP goal not met.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="164"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="43"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>poor ABPM, noncompliance, lab MAs</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Aml + Olm + Hctz</title>
          <description>amlodipine (aml) + olmesartan medoxomil (olm)+ hhdrochlorothiazide (hctz) is total number enrolled. Each group is the number of participants that were titrated to that dosing regimen as per the protocol. The total number of participants of the individual groups does not (and should not) equal the total number enrolled.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="207"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="59.1" spread="9.50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="122"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Hispanic or Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Not Hispanic or Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="153"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown or Not Reported</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>American Indian or Alaska Native</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Native Hawaiian or Other Pacific Islander</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black or African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="162"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>More than one race</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown or Not Reported</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Stage of hypertension</title>
          <description>Stage 1 or Stage 2 Hypertension. Stage 1 = Blood pressure &gt; 140/90 mm Hg. Stage 2 = systolic &gt;160 mm Hg or diastolic &gt; 100 mm Hg</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Stage 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="115"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Stage 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body mass index</title>
          <units>mg/m2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="32.80" spread="5.947"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Mean 24-hour ambulatory diastolic blood pressure</title>
          <units>mm Hg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="81.6" spread="9.76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Mean 24-hour ambulatory systolic blood pressure</title>
          <units>mm Hg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="144.4" spread="11.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Pulse rate</title>
          <units>beats per minute</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="73.75" spread="11.909"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Seated Diastolic Blood Pressure</title>
          <units>mm Hg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="89.1" spread="10.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Seated Systolic Blood Pressure</title>
          <units>mm Hg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="158.8" spread="13.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Years with diabetes</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6.44" spread="5.978"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change From Week 0 (Baseline) in Mean 24-hour Ambulatory Blood Pressure Monitoring (ABPM) Systolic Blood Pressure (SBP) After 12 Weeks of Active Treatment</title>
        <description>Change from week 0 (baseline) in mean 24-hour Ambulatory Blood Pressure Monitoring (ABPM) Systolic Blood Pressure (SBP) after 12 weeks of active treatment. change = week 12 - week 0.</description>
        <time_frame>week 0 - week 12</time_frame>
        <population>ABPM subjects analysis population included 165 subjects who received at least one dose of active study medication and provided valid ambulatory blood pressure monitoring measurements at baseline and week 12.</population>
        <group_list>
          <group group_id="O1">
            <title>Aml + Olm + Hctz</title>
            <description>amlodipine + olmesartan medoxomil, if required, + hydrochlorothiazide, if required</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Week 0 (Baseline) in Mean 24-hour Ambulatory Blood Pressure Monitoring (ABPM) Systolic Blood Pressure (SBP) After 12 Weeks of Active Treatment</title>
          <description>Change from week 0 (baseline) in mean 24-hour Ambulatory Blood Pressure Monitoring (ABPM) Systolic Blood Pressure (SBP) after 12 weeks of active treatment. change = week 12 - week 0.</description>
          <population>ABPM subjects analysis population included 165 subjects who received at least one dose of active study medication and provided valid ambulatory blood pressure monitoring measurements at baseline and week 12.</population>
          <units>mm Hg</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="165"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-19.9" spread="0.76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <method>t-test, 2 sided</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-19.9</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-21.5</ci_lower_limit>
            <ci_upper_limit>-18.4</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Week 0 (Baseline) in Mean ABPM Diastolic Blood Pressure (DBP) After 12 Weeks of Active Treatment</title>
        <description>24-hour mean DBP, Daytime mean DBP, Nighttime mean DBP, Last 6 hour mean DBP, Last 4 hour mean DBP, Last 2 hour mean DBP</description>
        <time_frame>week 0 - week 12 (24-hour, Daytime, Nighttime, Last 6 hour, Last 4 hour, Last 2 hour)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Aml + Olm + Hctz</title>
            <description>amlodipine + olmesartan medoxomil, if required, + hydrochlorothiazide, if required</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Week 0 (Baseline) in Mean ABPM Diastolic Blood Pressure (DBP) After 12 Weeks of Active Treatment</title>
          <description>24-hour mean DBP, Daytime mean DBP, Nighttime mean DBP, Last 6 hour mean DBP, Last 4 hour mean DBP, Last 2 hour mean DBP</description>
          <units>mm Hg</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="165"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>24-hour mean DBP change from baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-11.2" spread="0.50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>daytime mean DBP change from baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-11.7" spread="0.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>nighttime mean DBP change from baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-10.4" spread="0.68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>last 6 hour mean DBP change from baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-10.9" spread="0.64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>last 4 hour mean DBP change from baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-11.1" spread="0.68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>last 2 hour mean DBP change from baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-11.5" spread="0.76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Primary null hypothesis is change from baseline to week12 in ABPM is 0. Change from baseline to week12 is primary efficacy variable and used all ABPM subjects. Null hypothesis used 1-sample t-test on change. Sample size of 200 expected to provide 99% power at significance level of 0.05%.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <p_value_desc>24-hour mean DBP change from baseline to week 12.</p_value_desc>
            <method>t-test, 2 sided</method>
            <method_desc>standard 1-sample confidence interval construction using t-distribution with 164 degrees of freedom</method_desc>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-11.2</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-12.2</ci_lower_limit>
            <ci_upper_limit>-10.3</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Primary null hypothesis is change from baseline to week12 in ABPM is 0. Change from baseline to week12 is primary efficacy variable and used all ABPM subjects. Null hypothesis used 1-sample t-test on change. Sample size of 200 expected to provide 99% power at significance level of 0.05%.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <p_value_desc>daytime mean DBP change from baseline to week 12.</p_value_desc>
            <method>t-test, 2 sided</method>
            <method_desc>standard 1-sample confidence interval construction using t-distribution with 164 degrees of freedom</method_desc>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-11.7</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-12.9</ci_lower_limit>
            <ci_upper_limit>-10.5</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Primary null hypothesis is change from baseline to week12 in ABPM is 0. Change from baseline to week12 is primary efficacy variable and used all ABPM subjects. Null hypothesis used 1-sample t-test on change. Sample size of 200 expected to provide 99% power at significance level of 0.05%.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <p_value_desc>nighttime mean DBP change from baseline to week 12.</p_value_desc>
            <method>t-test, 2 sided</method>
            <method_desc>standard 1-sample confidence interval construction using t-distribution with 164 degrees of freedom</method_desc>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-10.4</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-11.7</ci_lower_limit>
            <ci_upper_limit>-9.0</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Primary null hypothesis is change from baseline to week12 in ABPM is 0. Change from baseline to week12 is primary efficacy variable and used all ABPM subjects. Null hypothesis used 1-sample t-test on change. Sample size of 200 expected to provide 99% power at significance level of 0.05%.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <p_value_desc>last 6 hours mean DBP change from baseline to week 12.</p_value_desc>
            <method>t-test, 2 sided</method>
            <method_desc>standard 1-sample confidence interval construction using t-distribution with 164 degrees of freedom</method_desc>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-10.9</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-12.2</ci_lower_limit>
            <ci_upper_limit>-9.7</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Primary null hypothesis is change from baseline to week12 in ABPM is 0. Change from baseline to week12 is primary efficacy variable and used all ABPM subjects. Null hypothesis used 1-sample t-test on change. Sample size of 200 expected to provide 99% power at significance level of 0.05%.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <p_value_desc>last 4 hours mean DBP change from baseline to week 12.</p_value_desc>
            <method>t-test, 2 sided</method>
            <method_desc>standard 1-sample confidence interval construction using t-distribution with 164 degrees of freedom</method_desc>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-11.1</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-12.4</ci_lower_limit>
            <ci_upper_limit>-9.8</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Primary null hypothesis is change from baseline to week12 in ABPM is 0. Change from baseline to week12 is primary efficacy variable and used all ABPM subjects. Null hypothesis used 1-sample t-test on change. Sample size of 200 expected to provide 99% power at significance level of 0.05%.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <p_value_desc>last 2 hours mean DBP change from baseline to week 12.</p_value_desc>
            <method>t-test, 2 sided</method>
            <method_desc>standard 1-sample confidence interval construction using t-distribution with 164 degrees of freedom</method_desc>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-11.5</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-13.1</ci_lower_limit>
            <ci_upper_limit>-10.0</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Week 0 (Baseline) in Mean ABPM SBP After 12 Weeks of Active Treatment</title>
        <description>Daytime mean SBP, Nighttime mean SBP, Last 6 hour mean SBP, Last 4 hour mean SBP, Last 2 hour mean SBP</description>
        <time_frame>week 0 - week 12 (24-hour, Daytime, Nighttime, Last 6 hour, Last 4 hour, Last 2 hour)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Aml + Olm + Hctz</title>
            <description>amlodipine + olmesartan medoxomil, if required, + hydrochlorothiazide, if required</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Week 0 (Baseline) in Mean ABPM SBP After 12 Weeks of Active Treatment</title>
          <description>Daytime mean SBP, Nighttime mean SBP, Last 6 hour mean SBP, Last 4 hour mean SBP, Last 2 hour mean SBP</description>
          <units>mm Hg</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="165"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>daytime mean SBP change from baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-20.8" spread="0.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>nighttime mean SBP change from baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-18.5" spread="0.95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>last 6 hours mean SBP change from baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-18.9" spread="0.93"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>last 4 hours mean SBP change from baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-19.1" spread="1.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>last 2 hours mean SBP change from baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-19.5" spread="1.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Primary null hypothesis is change from baseline to week12 in ABPM is 0. Change from baseline to week12 is primary efficacy variable and used all ABPM subjects. Null hypothesis used 1-sample t-test on change. Sample size of 200 expected to provide 99% power at significance level of 0.05%.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <p_value_desc>daytime mean SBP change from baseline to week 12.</p_value_desc>
            <method>t-test, 2 sided</method>
            <method_desc>standard 1-sample confidence interval construction using t-distribution with 164 degrees of freedom</method_desc>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-20.8</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-22.6</ci_lower_limit>
            <ci_upper_limit>-18.9</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Primary null hypothesis is change from baseline to week12 in ABPM is 0. Change from baseline to week12 is primary efficacy variable and used all ABPM subjects. Null hypothesis used 1-sample t-test on change. Sample size of 200 expected to provide 99% power at significance level of 0.05%.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <p_value_desc>nighttime mean SBP change from baseline to week 12.</p_value_desc>
            <method>t-test, 2 sided</method>
            <method_desc>standard 1-sample confidence interval construction using t-distribution with 164 degrees of freedom</method_desc>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-18.5</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-20.4</ci_lower_limit>
            <ci_upper_limit>-16.6</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Primary null hypothesis is change from baseline to week12 in ABPM is 0. Change from baseline to week12 is primary efficacy variable and used all ABPM subjects. Null hypothesis used 1-sample t-test on change. Sample size of 200 expected to provide 99% power at significance level of 0.05%.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <p_value_desc>last 6 hours mean SBP change from baseline to week 12.</p_value_desc>
            <method>t-test, 2 sided</method>
            <method_desc>standard 1-sample confidence interval construction using t-distribution with 164 degrees of freedom</method_desc>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-18.9</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-20.7</ci_lower_limit>
            <ci_upper_limit>-17.0</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Primary null hypothesis is change from baseline to week12 in ABPM is 0. Change from baseline to week12 is primary efficacy variable and used all ABPM subjects. Null hypothesis used 1-sample t-test on change. Sample size of 200 expected to provide 99% power at significance level of 0.05%.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <p_value_desc>last 4 hours mean SBP change from baseline to week 12.</p_value_desc>
            <method>t-test, 2 sided</method>
            <method_desc>standard 1-sample confidence interval construction using t-distribution with 164 degrees of freedom</method_desc>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-19.1</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-21.1</ci_lower_limit>
            <ci_upper_limit>-17.1</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Primary null hypothesis is change from baseline to week12 in ABPM is 0. Change from baseline to week12 is primary efficacy variable and used all ABPM subjects. Null hypothesis used 1-sample t-test on change. Sample size of 200 expected to provide 99% power at significance level of 0.05%.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <p_value_desc>last 2 hours mean SBP change from baseline to week 12.</p_value_desc>
            <method>t-test, 2 sided</method>
            <method_desc>standard 1-sample confidence interval construction using t-distribution with 164 degrees of freedom</method_desc>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-19.5</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-21.7</ci_lower_limit>
            <ci_upper_limit>-17.4</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Mean Seated Systolic Blood Pressure (SeSBP) From Week 0 (Baseline) After 3, 6, 9, 12, 15, and 18 Weeks</title>
        <description>change in mean SeSBP from week 0 (baseline) to Weeks 3, 6, 9, 12, 15, and 18.</description>
        <time_frame>week 0 - weeks 3, 6, 9, 12, 15, 18</time_frame>
        <population>Number of participants changed by week. Week 3 = 201, Week 6 = 192, week 9 = 184, week 12 = 177, week 15 = 172, week 18 = 164.</population>
        <group_list>
          <group group_id="O1">
            <title>Aml + Olm + Hctz</title>
            <description>amlodipine + olmesartan medoxomil, if required, + hydrochlorothiazide, if required</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Mean Seated Systolic Blood Pressure (SeSBP) From Week 0 (Baseline) After 3, 6, 9, 12, 15, and 18 Weeks</title>
          <description>change in mean SeSBP from week 0 (baseline) to Weeks 3, 6, 9, 12, 15, and 18.</description>
          <population>Number of participants changed by week. Week 3 = 201, Week 6 = 192, week 9 = 184, week 12 = 177, week 15 = 172, week 18 = 164.</population>
          <units>mm Hg</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="201"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>week 3 mean SBP change from baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-10.3" spread="0.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 6 mean SBP change from baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-17.9" spread="0.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 9 mean SBP change from baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-20.0" spread="1.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 12 mean SBP change from baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-23.7" spread="1.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 15 mean SBP change from baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-28.5" spread="1.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 18 mean SBP change from baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-31.1" spread="1.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Primary null hypothesis is change from baseline is 0. Null hypothesis used 1-sample t-test on change. Sample size of 200 expected to provide 99% power at significance level of 0.05%.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <p_value_desc>Change in mean seated systolic blood pressure from baseline to week 3.</p_value_desc>
            <method>t-test, 2 sided</method>
            <method_desc>standard 1-sample confidence interval construction using t-distribution with n-1 degrees of freedom</method_desc>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-10.3</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-12.0</ci_lower_limit>
            <ci_upper_limit>-8.6</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Primary null hypothesis is change from baseline is 0. Null hypothesis used 1-sample t-test on change. Sample size of 200 expected to provide 99% power at significance level of 0.05%.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <p_value_desc>Change in mean seated systolic blood pressure from baseline to week 6.</p_value_desc>
            <method>t-test, 2 sided</method>
            <method_desc>standard 1-sample confidence interval construction using t-distribution with n-1 degrees of freedom</method_desc>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-17.9</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-19.8</ci_lower_limit>
            <ci_upper_limit>-16.1</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Primary null hypothesis is change from baseline is 0. Null hypothesis used 1-sample t-test on change. Sample size of 200 expected to provide 99% power at significance level of 0.05%.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <p_value_desc>Change in mean seated systolic blood pressure from baseline to week 9</p_value_desc>
            <method>t-test, 2 sided</method>
            <method_desc>standard 1-sample confidence interval construction using t-distribution with n-1 degrees of freedom</method_desc>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-20.0</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-22.2</ci_lower_limit>
            <ci_upper_limit>-17.8</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Primary null hypothesis is change from baseline is 0. Null hypothesis used 1-sample t-test on change. Sample size of 200 expected to provide 99% power at significance level of 0.05%.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <p_value_desc>Change in mean seated systolic blood pressure from baseline to week 12</p_value_desc>
            <method>t-test, 2 sided</method>
            <method_desc>standard 1-sample confidence interval construction using t-distribution with n-1 degrees of freedom</method_desc>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-23.7</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-25.7</ci_lower_limit>
            <ci_upper_limit>-21.7</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Primary null hypothesis is change from baseline is 0. Null hypothesis used 1-sample t-test on change. Sample size of 200 expected to provide 99% power at significance level of 0.05%.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <p_value_desc>Change in mean seated systolic blood pressure from baseline to week 15</p_value_desc>
            <method>t-test, 2 sided</method>
            <method_desc>standard 1-sample confidence interval construction using t-distribution with n-1 degrees of freedom</method_desc>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-28.5</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-30.8</ci_lower_limit>
            <ci_upper_limit>-26.2</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Primary null hypothesis is change from baseline is 0. Null hypothesis used 1-sample t-test on change. Sample size of 200 expected to provide 99% power at significance level of 0.05%.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <p_value_desc>Change in mean seated systolic blood pressure from baseline to week 18</p_value_desc>
            <method>t-test, 2 sided</method>
            <method_desc>standard 1-sample confidence interval construction using t-distribution with n-1 degrees of freedom</method_desc>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-31.1</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-33.3</ci_lower_limit>
            <ci_upper_limit>-28.8</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Mean Seated Diastolic Blood Pressure (SeDBP) From Week 0 (Baseline) After 3, 6, 9, 12, 15, and 18 Weeks</title>
        <description>change in mean SeDBP from week 0 (baseline) to Weeks 3, 6, 9, 12, 15, and 18.</description>
        <time_frame>week 0 - weeks 3, 6, 9, 12, 15, 18</time_frame>
        <population>Number of participants changed by week. Week 3 = 201, Week 6 = 192, week 9 = 184, week 12 = 177, week 15 = 172, week 18 = 164.</population>
        <group_list>
          <group group_id="O1">
            <title>Aml + Olm + Hctz</title>
            <description>amlodipine + olmesartan medoxomil, if required, + hydrochlorothiazide, if required</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Mean Seated Diastolic Blood Pressure (SeDBP) From Week 0 (Baseline) After 3, 6, 9, 12, 15, and 18 Weeks</title>
          <description>change in mean SeDBP from week 0 (baseline) to Weeks 3, 6, 9, 12, 15, and 18.</description>
          <population>Number of participants changed by week. Week 3 = 201, Week 6 = 192, week 9 = 184, week 12 = 177, week 15 = 172, week 18 = 164.</population>
          <units>mm Hg</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="201"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>week 3 mean seDBP change from baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-4.1" spread="0.50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 6 mean seDBP change from baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-8.2" spread="0.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 9 mean seDBP change from baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-9.7" spread="0.64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 12 mean seDBP change from baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-11.2" spread="0.64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 15 mean seDBP change from baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-14.4" spread="0.66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>week 18 mean seDBP change from baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-15.1" spread="0.72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Primary null hypothesis is change from baseline is 0. Null hypothesis used 1-sample t-test on change. Sample size of 200 expected to provide 99% power at significance level of 0.05%.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <p_value_desc>Change in mean seated diastolic blood pressure from baseline to week 3.</p_value_desc>
            <method>t-test, 2 sided</method>
            <method_desc>standard 1-sample confidence interval construction using t-distribution with n-1 degrees of freedom</method_desc>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-4.1</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-5.1</ci_lower_limit>
            <ci_upper_limit>-3.1</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Primary null hypothesis is change from baseline is 0. Null hypothesis used 1-sample t-test on change. Sample size of 200 expected to provide 99% power at significance level of 0.05%.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <p_value_desc>Change in mean seated diastolic blood pressure from baseline to week 6</p_value_desc>
            <method>t-test, 2 sided</method>
            <method_desc>standard 1-sample confidence interval construction using t-distribution with n-1 degrees of freedom</method_desc>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-8.2</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-9.4</ci_lower_limit>
            <ci_upper_limit>-7.1</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Primary null hypothesis is change from baseline is 0. Null hypothesis used 1-sample t-test on change. Sample size of 200 expected to provide 99% power at significance level of 0.05%.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <p_value_desc>Change in mean seated diastolic blood pressure from baseline to week 9</p_value_desc>
            <method>t-test, 2 sided</method>
            <method_desc>standard 1-sample confidence interval construction using t-distribution with n-1 degrees of freedom</method_desc>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-9.7</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-10.9</ci_lower_limit>
            <ci_upper_limit>-8.4</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Primary null hypothesis is change from baseline is 0. Null hypothesis used 1-sample t-test on change. Sample size of 200 expected to provide 99% power at significance level of 0.05%.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <p_value_desc>Change in mean seated diastolic blood pressure from baseline to week 12</p_value_desc>
            <method>t-test, 2 sided</method>
            <method_desc>standard 1-sample confidence interval construction using t-distribution with n-1 degrees of freedom</method_desc>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-11.2</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-12.5</ci_lower_limit>
            <ci_upper_limit>-9.9</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Primary null hypothesis is change from baseline is 0. Null hypothesis used 1-sample t-test on change. Sample size of 200 expected to provide 99% power at significance level of 0.05%.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <p_value_desc>Change in mean seated diastolic blood pressure from baseline to week 15</p_value_desc>
            <method>t-test, 2 sided</method>
            <method_desc>standard 1-sample confidence interval construction using t-distribution with n-1 degrees of freedom</method_desc>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-14.4</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-15.7</ci_lower_limit>
            <ci_upper_limit>-13.1</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Primary null hypothesis is change from baseline is 0. Null hypothesis used 1-sample t-test on change. Sample size of 200 expected to provide 99% power at significance level of 0.05%.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <p_value_desc>Change in mean seated diastolic blood pressure from baseline to week 18</p_value_desc>
            <method>t-test, 2 sided</method>
            <method_desc>standard 1-sample confidence interval construction using t-distribution with n-1 degrees of freedom</method_desc>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-15.1</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-16.5</ci_lower_limit>
            <ci_upper_limit>-13.6</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Achieving Mean 24-hour Ambulatory Blood Pressure Thresholds at Week 12</title>
        <description>number of participants achieving mean 24-hour ambulatory blood pressure thresholds BP&lt;135/85, BP&lt;130/80, BP&lt;125/75, BP&lt;120/80, SBP&lt;135, SBP&lt;130, SBP&lt;125, SBP&lt;120, DBP&lt;85, DBP&lt;80, DBP&lt;75 at week 12</description>
        <time_frame>week 0 - week 12</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Aml + Olm + Hctz</title>
            <description>amlodipine + olmesartan medoxomil, if required, + hydrochlorothiazide, if required</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Achieving Mean 24-hour Ambulatory Blood Pressure Thresholds at Week 12</title>
          <description>number of participants achieving mean 24-hour ambulatory blood pressure thresholds BP&lt;135/85, BP&lt;130/80, BP&lt;125/75, BP&lt;120/80, SBP&lt;135, SBP&lt;130, SBP&lt;125, SBP&lt;120, DBP&lt;85, DBP&lt;80, DBP&lt;75 at week 12</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="165"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>mean 24-hour BP &lt;135/85</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="140"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean 24-hour BP &lt;130/80</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="116"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean 24-hour BP &lt;125/75</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean 24-hour BP &lt;120/80</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean 24-hour SBP &lt;135</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="140"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean 24-hour SBP &lt;130</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="120"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean 24-hour SBP &lt;125</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean 24-hour SBP &lt;120</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean 24-hour DBP &lt;85</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="158"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean 24-hour DBP &lt;80</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="146"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean 24-hour DBP &lt;75</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="121"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Achieving Mean Daytime Ambulatory Blood Pressure Thresholds at Week 12</title>
        <description>number of participants achieving mean daytime ambulatory blood pressure thresholds BP&lt;135/85, BP&lt;130/80, BP&lt;125/75, BP&lt;120/80, SBP&lt;135, SBP&lt;130, SBP&lt;125, SBP&lt;120, DBP&lt;85, DBP&lt;80, DBP&lt;75 at week 12</description>
        <time_frame>week 0 - week 12</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Aml + Olm + Hctz</title>
            <description>amlodipine + olmesartan medoxomil, if required, + hydrochlorothiazide, if required</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Achieving Mean Daytime Ambulatory Blood Pressure Thresholds at Week 12</title>
          <description>number of participants achieving mean daytime ambulatory blood pressure thresholds BP&lt;135/85, BP&lt;130/80, BP&lt;125/75, BP&lt;120/80, SBP&lt;135, SBP&lt;130, SBP&lt;125, SBP&lt;120, DBP&lt;85, DBP&lt;80, DBP&lt;75 at week 12</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="165"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>mean daytime BP &lt; 135/85</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="116"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean daytime BP &lt; 130/80</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean daytime BP &lt; 125/75</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean daytime BP &lt; 120/80</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean daytime SBP &lt; 135</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="118"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean daytime SBP &lt; 130</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean daytime SBP &lt; 125</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean daytime SBP &lt; 120</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean daytime DBP &lt; 85</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="151"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean daytime DBP &lt; 80</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="124"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean daytime DBP &lt; 75</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Achieving Mean Nighttime Ambulatory Blood Pressure Thresholds at Week 12</title>
        <description>number of participants achieving mean nighttime ambulatory blood pressure thresholds BP&lt;135/85, BP&lt;130/80, BP&lt;125/75, BP&lt;120/80, BP&lt;120/70, SBP&lt;135, SBP&lt;130, SBP&lt;125, SBP&lt;120, DBP&lt;85, DBP&lt;80, DBP&lt;75, DBP&lt;70 at week 12</description>
        <time_frame>week 0 - week 12</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Aml + Olm + Hctz</title>
            <description>amlodipine + olmesartan medoxomil, if required, + hydrochlorothiazide, if required</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Achieving Mean Nighttime Ambulatory Blood Pressure Thresholds at Week 12</title>
          <description>number of participants achieving mean nighttime ambulatory blood pressure thresholds BP&lt;135/85, BP&lt;130/80, BP&lt;125/75, BP&lt;120/80, BP&lt;120/70, SBP&lt;135, SBP&lt;130, SBP&lt;125, SBP&lt;120, DBP&lt;85, DBP&lt;80, DBP&lt;75, DBP&lt;70 at week 12</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="165"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>mean nighttime BP &lt; 135/85</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="152"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean nighttime BP &lt; 130/80</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="137"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean nighttime BP &lt; 125/75</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="119"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean nighttime BP &lt; 120/80</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="112"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean nighttime BP &lt; 120/70</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="101"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean nighttime SBP &lt; 135</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="154"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean nighttime SBP &lt; 130</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="139"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean nighttime SBP &lt; 125</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="123"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean nighttime SBP &lt; 120</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="112"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean nighttime DBP &lt; 85</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="160"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean nighttime DBP &lt; 80</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="158"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean nighttime DBP &lt; 75</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="147"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean nighttime DBP &lt; 70</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="124"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Achieving Mean Last 6 Hour Ambulatory Blood Pressure Thresholds at Week 12</title>
        <description>number participants achieving mean last 6 hour ambulatory blood pressure thresholds BP&lt;135/85, BP&lt;130/80, BP&lt;125/75, BP&lt;120/80, SBP&lt;135, SBP&lt;130, SBP&lt;125, SBP&lt;120, DBP&lt;85, DBP&lt;80, DBP&lt;75 at week 12</description>
        <time_frame>week 0 - week 12</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Aml + Olm + Hctz</title>
            <description>amlodipine + olmesartan medoxomil, if required, + hydrochlorothiazide, if required</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Achieving Mean Last 6 Hour Ambulatory Blood Pressure Thresholds at Week 12</title>
          <description>number participants achieving mean last 6 hour ambulatory blood pressure thresholds BP&lt;135/85, BP&lt;130/80, BP&lt;125/75, BP&lt;120/80, SBP&lt;135, SBP&lt;130, SBP&lt;125, SBP&lt;120, DBP&lt;85, DBP&lt;80, DBP&lt;75 at week 12</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="165"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>mean last 6 hour BP &lt; 135/85</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="135"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean last 6 hour BP &lt; 130/80</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="124"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean last 6 hour BP &lt; 125/75</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="101"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean last 6 hour BP &lt; 120/80</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean last 6 hour SBP &lt; 135</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="143"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean last 6 hour SBP &lt; 130</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="127"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean last 6 hour SBP &lt; 125</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="108"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean last 6 hour SBP &lt; 120</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean last 6 hour DBP &lt; 85</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="157"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean last 6 hour DBP &lt; 80</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="146"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean last 6 hour DBP &lt; 75</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="130"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Achieving Mean Last 4 Hour Ambulatory Blood Pressure Thresholds at Week 12</title>
        <description>number of participants achieving mean last 4 hour ambulatory blood pressure thresholds BP&lt;135/85, BP&lt;130/80, BP&lt;125/75, BP&lt;120/80, SBP&lt;135, SBP&lt;130, SBP&lt;125, SBP&lt;120, DBP&lt;85, DBP&lt;80, DBP&lt;75 at week 12</description>
        <time_frame>week 0 - week 12</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Aml + Olm + Hctz</title>
            <description>amlodipine + olmesartan medoxomil, if required, + hydrochlorothiazide, if required</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Achieving Mean Last 4 Hour Ambulatory Blood Pressure Thresholds at Week 12</title>
          <description>number of participants achieving mean last 4 hour ambulatory blood pressure thresholds BP&lt;135/85, BP&lt;130/80, BP&lt;125/75, BP&lt;120/80, SBP&lt;135, SBP&lt;130, SBP&lt;125, SBP&lt;120, DBP&lt;85, DBP&lt;80, DBP&lt;75 at week 12</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="165"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>mean last 4 hour BP &lt; 135/85</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="129"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean last 4 hour BP &lt; 130/80</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="107"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean last 4 hour BP &lt; 125/75</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean last 4 hour BP &lt; 120/80</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean last 4 hour SBP &lt; 135</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="131"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean last 4 hour SBP &lt; 130</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="114"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean last 4 hour SBP &lt; 125</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="102"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean last 4 hour SBP &lt; 120</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean last 4 hour DBP &lt; 85</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="150"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean last 4 hour DBP &lt; 80</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="137"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean last 4 hour DBP &lt; 75</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="120"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Achieving Mean Last 2 Hour Ambulatory Blood Pressure Thresholds at Week 12</title>
        <description>number of participants achieving mean last 2 hour ambulatory blood pressure thresholds BP&lt;135/85, BP&lt;130/80, BP&lt;125/75, BP&lt;120/80, SBP&lt;135, SBP&lt;130, SBP&lt;125, SBP&lt;120, DBP&lt;85, DBP&lt;80, DBP&lt;75 at week 12</description>
        <time_frame>week 0 - week 12</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Aml + Olm + Hctz</title>
            <description>amlodipine + olmesartan medoxomil, if required, + hydrochlorothiazide, if required</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Achieving Mean Last 2 Hour Ambulatory Blood Pressure Thresholds at Week 12</title>
          <description>number of participants achieving mean last 2 hour ambulatory blood pressure thresholds BP&lt;135/85, BP&lt;130/80, BP&lt;125/75, BP&lt;120/80, SBP&lt;135, SBP&lt;130, SBP&lt;125, SBP&lt;120, DBP&lt;85, DBP&lt;80, DBP&lt;75 at week 12</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="165"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>mean last 2 hour BP &lt; 135/85</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="110"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean last 2 hour BP &lt; 130/80</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean last 2 hour BP &lt; 125/75</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean last 2 hour BP &lt; 120/80</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean last 2 hour SBP &lt; 135</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="115"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean last 2 hour SBP &lt; 130</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean last 2 hour SBP &lt; 125</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean last 2 hour SBP &lt; 120</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean last 2 hour DBP &lt; 85</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="145"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean last 2 hour DBP &lt; 80</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="125"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean last 2 hour DBP &lt; 75</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Achieving Seated Systolic and Diastolic Blood Pressure Thresholds at Week 3</title>
        <description>number of participants achieving seated systolic and diastolic blood pressure thresholds BP&lt;135/85, BP&lt;130/80, BP&lt;125/75, BP&lt;120/80, SBP&lt;135, SBP&lt;130, SBP&lt;125, SBP&lt;120, DBP&lt;85, DBP&lt;80, DBP&lt;75 at week 3</description>
        <time_frame>week 0 - week 3</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Aml + Olm + Hctz</title>
            <description>amlodipine + olmesartan medoxomil, if required, + hydrochlorothiazide, if required</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Achieving Seated Systolic and Diastolic Blood Pressure Thresholds at Week 3</title>
          <description>number of participants achieving seated systolic and diastolic blood pressure thresholds BP&lt;135/85, BP&lt;130/80, BP&lt;125/75, BP&lt;120/80, SBP&lt;135, SBP&lt;130, SBP&lt;125, SBP&lt;120, DBP&lt;85, DBP&lt;80, DBP&lt;75 at week 3</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="201"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>mean BP &lt; 135/85</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean BP &lt; 130/80</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean BP &lt; 125/75</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean BP &lt; 120/80</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean SBP &lt; 135</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean SBP &lt; 130</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean SBP &lt; 125</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean SBP &lt; 120</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean DBP &lt; 85</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean DBP &lt; 80</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean DBP &lt; 75</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Achieving Seated Systolic and Diastolic Blood Pressure Thresholds at Week 6</title>
        <description>number of participants achieving seated systolic and diastolic blood pressure thresholds BP&lt;135/85, BP&lt;130/80, BP&lt;125/75, BP&lt;120/80, SBP&lt;135, SBP&lt;130, SBP&lt;125, SBP&lt;120, DBP&lt;85, DBP&lt;80, DBP&lt;75 at week 6</description>
        <time_frame>week 0 - week 6</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Aml + Olm + Hctz</title>
            <description>amlodipine + olmesartan medoxomil, if required, + hydrochlorothiazide, if required</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Achieving Seated Systolic and Diastolic Blood Pressure Thresholds at Week 6</title>
          <description>number of participants achieving seated systolic and diastolic blood pressure thresholds BP&lt;135/85, BP&lt;130/80, BP&lt;125/75, BP&lt;120/80, SBP&lt;135, SBP&lt;130, SBP&lt;125, SBP&lt;120, DBP&lt;85, DBP&lt;80, DBP&lt;75 at week 6</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="192"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>mean BP &lt; 135/85</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean BP &lt; 130/80</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean BP &lt; 125/75</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean BP &lt; 120/80</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean SBP &lt; 135</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean SBP &lt; 130</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean SBP &lt; 125</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean SBP &lt; 120</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean DBP &lt; 85</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="127"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean DBP &lt; 80</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean DBP &lt; 75</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Achieving Seated Systolic and Diastolic Blood Pressure Thresholds at Week 9</title>
        <description>number of participants achieving seated systolic and diastolic blood pressure thresholds BP&lt;135/85, BP&lt;130/80, BP&lt;125/75, BP&lt;120/80, SBP&lt;135, SBP&lt;130, SBP&lt;125, SBP&lt;120, DBP&lt;85, DBP&lt;80, DBP&lt;75 at week 9</description>
        <time_frame>week 0 - week 9</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Aml + Olm + Hctz</title>
            <description>amlodipine + olmesartan medoxomil, if required, + hydrochlorothiazide, if required</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Achieving Seated Systolic and Diastolic Blood Pressure Thresholds at Week 9</title>
          <description>number of participants achieving seated systolic and diastolic blood pressure thresholds BP&lt;135/85, BP&lt;130/80, BP&lt;125/75, BP&lt;120/80, SBP&lt;135, SBP&lt;130, SBP&lt;125, SBP&lt;120, DBP&lt;85, DBP&lt;80, DBP&lt;75 at week 9</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="184"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>mean BP &lt; 135/85</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean BP &lt; 130/80</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean BP &lt; 125/75</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean BP &lt; 120/80</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean SBP &lt; 135</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean SBP &lt; 130</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean SBP &lt; 125</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean SBP &lt; 120</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean DBP &lt; 85</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="132"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean DBP &lt; 80</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean DBP &lt; 75</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Achieving Seated Systolic and Diastolic Blood Pressure Thresholds at Week 12</title>
        <description>number of participants achieving seated systolic and diastolic blood pressure thresholds BP&lt;135/85, BP&lt;130/80, BP&lt;125/75, BP&lt;120/80, SBP&lt;135, SBP&lt;130, SBP&lt;125, SBP&lt;120, DBP&lt;85, DBP&lt;80, DBP&lt;75 at week 12</description>
        <time_frame>week 0 - week 12</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Aml + Olm + Hctz</title>
            <description>amlodipine + olmesartan medoxomil, if required, + hydrochlorothiazide, if required</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Achieving Seated Systolic and Diastolic Blood Pressure Thresholds at Week 12</title>
          <description>number of participants achieving seated systolic and diastolic blood pressure thresholds BP&lt;135/85, BP&lt;130/80, BP&lt;125/75, BP&lt;120/80, SBP&lt;135, SBP&lt;130, SBP&lt;125, SBP&lt;120, DBP&lt;85, DBP&lt;80, DBP&lt;75 at week 12</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="177"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>mean BP &lt; 135/85</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean BP &lt; 130/80</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean BP &lt; 125/75</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean BP &lt; 120/80</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean SBP &lt; 135</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="93"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean SBP &lt; 130</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean SBP &lt; 125</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean SBP &lt; 120</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean DBP &lt; 85</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="134"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean DBP &lt; 80</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="105"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean DBP &lt; 75</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Achieving Seated Systolic and Diastolic Blood Pressure Thresholds at Week 15</title>
        <description>number of participants achieving seated systolic and diastolic blood pressure thresholds BP&lt;135/85, BP&lt;130/80, BP&lt;125/75, BP&lt;120/80, SBP&lt;135, SBP&lt;130, SBP&lt;125, SBP&lt;120, DBP&lt;85, DBP&lt;80, DBP&lt;75 at week 15</description>
        <time_frame>week 0 - week 15</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Aml + Olm + Hctz</title>
            <description>amlodipine + olmesartan medoxomil, if required, + hydrochlorothiazide, if required</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Achieving Seated Systolic and Diastolic Blood Pressure Thresholds at Week 15</title>
          <description>number of participants achieving seated systolic and diastolic blood pressure thresholds BP&lt;135/85, BP&lt;130/80, BP&lt;125/75, BP&lt;120/80, SBP&lt;135, SBP&lt;130, SBP&lt;125, SBP&lt;120, DBP&lt;85, DBP&lt;80, DBP&lt;75 at week 15</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="172"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>mean BP &lt; 135/85</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="114"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean BP &lt; 130/80</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean BP &lt; 125/75</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean BP &lt; 120/80</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean SBP &lt; 135</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="116"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean SBP &lt; 130</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean SBP &lt; 125</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean SBP &lt; 120</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean DBP &lt; 85</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="153"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean DBP &lt; 80</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="122"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean DBP &lt; 75</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Achieving Seated Systolic and Diastolic Blood Pressure Thresholds at Week 18</title>
        <description>number of participants achieving seated systolic and diastolic blood pressure thresholds BP&lt;135/85, BP&lt;130/80, BP&lt;125/75, BP&lt;120/80, SBP&lt;135, SBP&lt;130, SBP&lt;125, SBP&lt;120, DBP&lt;85, DBP&lt;80, DBP&lt;75 at week 18</description>
        <time_frame>week 0 - week 18</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Aml + Olm + Hctz</title>
            <description>amlodipine + olmesartan medoxomil, if required, + hydrochlorothiazide, if required</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Achieving Seated Systolic and Diastolic Blood Pressure Thresholds at Week 18</title>
          <description>number of participants achieving seated systolic and diastolic blood pressure thresholds BP&lt;135/85, BP&lt;130/80, BP&lt;125/75, BP&lt;120/80, SBP&lt;135, SBP&lt;130, SBP&lt;125, SBP&lt;120, DBP&lt;85, DBP&lt;80, DBP&lt;75 at week 18</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="164"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>mean BP &lt; 135/85</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="117"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean BP &lt; 130/80</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean BP &lt; 125/75</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean BP &lt; 120/80</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean SBP &lt; 135</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="123"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean SBP &lt; 130</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="101"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean SBP &lt; 125</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean SBP &lt; 120</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean DBP &lt; 85</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="147"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean DBP &lt; 80</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="128"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean DBP &lt; 75</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Achieving Mean 24 Hour Ambulatory Systolic and Diastolic Blood Pressure Reductions at Week 12</title>
        <description>number of participants achieving mean 24 hour ambulatory systolic and diastolic blood pressure reductions of; SBP reduction &lt;= 15 mmHg, SBP reduction &gt; 15 mmHg &amp; &lt;= 30 mmHg, SBP reduction &gt; 30 mmHg &amp; &lt;= 45 mmHg, SBP reduction &gt; 45 mmHg, DBP reduction &lt;= 10 mmHg, DBP reduction &gt; 10 mmHg &amp; &lt;= 15 mmHg, DBP reduction &gt; 15 mmHg &amp; &lt;= 20 mmHg, DBP reduction &gt; 20 mmHg at week 12</description>
        <time_frame>week 0 - week 12</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Aml + Olm + Hctz</title>
            <description>amlodipine + olmesartan medoxomil, if required, + hydrochlorothiazide, if required</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Achieving Mean 24 Hour Ambulatory Systolic and Diastolic Blood Pressure Reductions at Week 12</title>
          <description>number of participants achieving mean 24 hour ambulatory systolic and diastolic blood pressure reductions of; SBP reduction &lt;= 15 mmHg, SBP reduction &gt; 15 mmHg &amp; &lt;= 30 mmHg, SBP reduction &gt; 30 mmHg &amp; &lt;= 45 mmHg, SBP reduction &gt; 45 mmHg, DBP reduction &lt;= 10 mmHg, DBP reduction &gt; 10 mmHg &amp; &lt;= 15 mmHg, DBP reduction &gt; 15 mmHg &amp; &lt;= 20 mmHg, DBP reduction &gt; 20 mmHg at week 12</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="165"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>mean 24-hour SBP reduction =&lt;15 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean 24-hour SBP reduction &gt;15 &amp; =&lt;30 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean 24-hour SBP reduction &gt;30 &amp; =&lt;45 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean 24-hour SBP reduction &gt;45 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean 24-hour DBP reduction =&lt;10 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean 24-hour DBP reduction &gt;10 &amp; =&lt;15 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean 24-hour DBP reduction &gt;15 &amp; =&lt;20 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean 24-hour DBP reduction &gt;20 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Achieving Mean Daytime Ambulatory Systolic and Diastolic Blood Pressure Reductions at Week 12</title>
        <description>number of participants achieving mean daytime ambulatory systolic and diastolic blood pressure reductions of; SBP reduction &lt;= 15 mmHg, SBP reduction &gt; 15 mmHg &amp; &lt;= 30 mmHg, SBP reduction &gt; 30 mmHg &amp; &lt;= 45 mmHg, SBP reduction &gt; 45 mmHg, DBP reduction &lt;= 10 mmHg, DBP reduction &gt; 10 mmHg &amp; &lt;= 15 mmHg, DBP reduction &gt; 15 mmHg &amp; &lt;= 20 mmHg, DBP reduction &gt; 20 mmHg at week 12</description>
        <time_frame>week 0 - week 12</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Aml + Olm + Hctz</title>
            <description>amlodipine + olmesartan medoxomil, if required, + hydrochlorothiazide, if required</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Achieving Mean Daytime Ambulatory Systolic and Diastolic Blood Pressure Reductions at Week 12</title>
          <description>number of participants achieving mean daytime ambulatory systolic and diastolic blood pressure reductions of; SBP reduction &lt;= 15 mmHg, SBP reduction &gt; 15 mmHg &amp; &lt;= 30 mmHg, SBP reduction &gt; 30 mmHg &amp; &lt;= 45 mmHg, SBP reduction &gt; 45 mmHg, DBP reduction &lt;= 10 mmHg, DBP reduction &gt; 10 mmHg &amp; &lt;= 15 mmHg, DBP reduction &gt; 15 mmHg &amp; &lt;= 20 mmHg, DBP reduction &gt; 20 mmHg at week 12</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="165"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>mean daytime SBP reduction =&lt;15 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean daytime SBP reduction &gt;15 &amp; =&lt;30 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean daytime SBP reduction &gt;30 &amp; =&lt;45 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean daytime SBP reduction &gt;45 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean daytime DBP reduction =&lt;10 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean daytime DBP reduction &gt;10 &amp; =&lt;15 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean daytime DBP reduction &gt;15 &amp; =&lt;20 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean daytime DBP reduction &gt;20 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Achieving Mean Nighttime Ambulatory Systolic and Diastolic Blood Pressure Reductions at Week 12</title>
        <description>number of participants achieving mean nighttime ambulatory systolic and diastolic blood pressure reductions of; SBP reduction &lt;= 15 mmHg, SBP reduction &gt; 15 mmHg &amp; &lt;= 30 mmHg, SBP reduction &gt; 30 mmHg &amp; &lt;= 45 mmHg, SBP reduction &gt; 45 mmHg, DBP reduction &lt;= 10 mmHg, DBP reduction &gt; 10 mmHg &amp; &lt;= 15 mmHg, DBP reduction &gt; 15 mmHg &amp; &lt;= 20 mmHg, DBP reduction &gt; 20 mmHg at week 12</description>
        <time_frame>week 0 - week 12</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Aml + Olm + Hctz</title>
            <description>amlodipine + olmesartan medoxomil, if required, + hydrochlorothiazide, if required</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Achieving Mean Nighttime Ambulatory Systolic and Diastolic Blood Pressure Reductions at Week 12</title>
          <description>number of participants achieving mean nighttime ambulatory systolic and diastolic blood pressure reductions of; SBP reduction &lt;= 15 mmHg, SBP reduction &gt; 15 mmHg &amp; &lt;= 30 mmHg, SBP reduction &gt; 30 mmHg &amp; &lt;= 45 mmHg, SBP reduction &gt; 45 mmHg, DBP reduction &lt;= 10 mmHg, DBP reduction &gt; 10 mmHg &amp; &lt;= 15 mmHg, DBP reduction &gt; 15 mmHg &amp; &lt;= 20 mmHg, DBP reduction &gt; 20 mmHg at week 12</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="165"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>mean nighttime SBP reduction =&lt;15 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean nighttime SBP reduction &gt;15 &amp; =&lt;30 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean nighttime SBP reduction &gt;30 &amp; =&lt;45 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean nighttime SBP reduction &gt;45 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean nighttime DBP reduction =&lt;10 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean nighttime SBP reduction &gt;10 &amp; =&lt;15 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean nighttime SBP reduction &gt;15 &amp; =&lt;20 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean nighttime DBP reduction &gt;20 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Achieving Mean Last 6 Hour Ambulatory Systolic and Diastolic Blood Pressure Reductions at Week 12</title>
        <description>number of participants achieving mean last 6 hour ambulatory systolic and diastolic blood pressure reductions of; SBP reduction &lt;= 15 mmHg, SBP reduction &gt; 15 mmHg &amp; &lt;= 30 mmHg, SBP reduction &gt; 30 mmHg &amp; &lt;= 45 mmHg, SBP reduction &gt; 45 mmHg, DBP reduction &lt;= 10 mmHg, DBP reduction &gt; 10 mmHg &amp; &lt;= 15 mmHg, DBP reduction &gt; 15 mmHg &amp; &lt;= 20 mmHg, DBP reduction &gt; 20 mmHg at week 12</description>
        <time_frame>week 0 - week 12</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Aml + Olm + Hctz</title>
            <description>amlodipine + olmesartan medoxomil, if required, + hydrochlorothiazide, if required</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Achieving Mean Last 6 Hour Ambulatory Systolic and Diastolic Blood Pressure Reductions at Week 12</title>
          <description>number of participants achieving mean last 6 hour ambulatory systolic and diastolic blood pressure reductions of; SBP reduction &lt;= 15 mmHg, SBP reduction &gt; 15 mmHg &amp; &lt;= 30 mmHg, SBP reduction &gt; 30 mmHg &amp; &lt;= 45 mmHg, SBP reduction &gt; 45 mmHg, DBP reduction &lt;= 10 mmHg, DBP reduction &gt; 10 mmHg &amp; &lt;= 15 mmHg, DBP reduction &gt; 15 mmHg &amp; &lt;= 20 mmHg, DBP reduction &gt; 20 mmHg at week 12</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="165"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>mean last 6 hour SBP reduction =&lt;15 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean last 6 hour SBP reduction &gt;15 &amp; =&lt;30 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean last 6 hour SBP reduction &gt;30 &amp; =&lt;45 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean last 6 hour SBP reduction &gt;45 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean last 6 hour DBP reduction =&lt;10 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean last 6 hour DBP reduction &gt;10 &amp; =&lt;15 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean last 6 hour DBP reduction &gt;15 &amp; =&lt;20 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean last 6 hour DBP reduction &gt;20 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Achieving Mean Last 4 Hour Ambulatory Systolic and Diastolic Blood Pressure Reductions</title>
        <description>number of participants achieving mean last 4 hour ambulatory systolic and diastolic blood pressure reductions of; SBP reduction &lt;= 15 mmHg, SBP reduction &gt; 15 mmHg &amp; &lt;= 30 mmHg, SBP reduction &gt; 30 mmHg &amp; &lt;= 45 mmHg, SBP reduction &gt; 45 mmHg, DBP reduction &lt;= 10 mmHg, DBP reduction &gt; 10 mmHg &amp; &lt;= 15 mmHg, DBP reduction &gt; 15 mmHg &amp; &lt;= 20 mmHg, DBP reduction &gt; 20 mmHg at week 12</description>
        <time_frame>week 0 - week 12</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Aml + Olm + Hctz</title>
            <description>amlodipine + olmesartan medoxomil, if required, + hydrochlorothiazide, if required</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Achieving Mean Last 4 Hour Ambulatory Systolic and Diastolic Blood Pressure Reductions</title>
          <description>number of participants achieving mean last 4 hour ambulatory systolic and diastolic blood pressure reductions of; SBP reduction &lt;= 15 mmHg, SBP reduction &gt; 15 mmHg &amp; &lt;= 30 mmHg, SBP reduction &gt; 30 mmHg &amp; &lt;= 45 mmHg, SBP reduction &gt; 45 mmHg, DBP reduction &lt;= 10 mmHg, DBP reduction &gt; 10 mmHg &amp; &lt;= 15 mmHg, DBP reduction &gt; 15 mmHg &amp; &lt;= 20 mmHg, DBP reduction &gt; 20 mmHg at week 12</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="165"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>mean last 4 hour SBP reduction =&lt;15 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean last 4 hour SBP reduction &gt;15 &amp; =&lt;30 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean last 4 hour SBP reduction &gt;30 &amp; =&lt;45 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean last 4 hour SBP reduction &gt;45 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean last 4 hour DBP reduction =&lt;10 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean last 4 hour DBP reduction &gt;10 &amp; =&lt;15 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean last 4 hour DBP reduction &gt;15 &amp; =&lt;20 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean last 4 hour DBP reduction &gt;20 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Achieving Mean Last 2 Hour Ambulatory Systolic and Diastolic Blood Pressure Reductions at Week 12</title>
        <description>number of participants achieving mean last 2 hour ambulatory systolic and diastolic blood pressure reductions of; SBP reduction &lt;= 15 mmHg, SBP reduction &gt; 15 mmHg &amp; &lt;= 30 mmHg, SBP reduction &gt; 30 mmHg &amp; &lt;= 45 mmHg, SBP reduction &gt; 45 mmHg, DBP reduction &lt;= 10 mmHg, DBP reduction &gt; 10 mmHg &amp; &lt;= 15 mmHg, DBP reduction &gt; 15 mmHg &amp; &lt;= 20 mmHg, DBP reduction &gt; 20 mmHg at week 12</description>
        <time_frame>week 0 - week 12</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Aml + Olm + Hctz</title>
            <description>amlodipine + olmesartan medoxomil, if required, + hydrochlorothiazide, if required</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Achieving Mean Last 2 Hour Ambulatory Systolic and Diastolic Blood Pressure Reductions at Week 12</title>
          <description>number of participants achieving mean last 2 hour ambulatory systolic and diastolic blood pressure reductions of; SBP reduction &lt;= 15 mmHg, SBP reduction &gt; 15 mmHg &amp; &lt;= 30 mmHg, SBP reduction &gt; 30 mmHg &amp; &lt;= 45 mmHg, SBP reduction &gt; 45 mmHg, DBP reduction &lt;= 10 mmHg, DBP reduction &gt; 10 mmHg &amp; &lt;= 15 mmHg, DBP reduction &gt; 15 mmHg &amp; &lt;= 20 mmHg, DBP reduction &gt; 20 mmHg at week 12</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="165"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>mean last 2 hour SBP reduction =&lt;15 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean last 2 hour SBP reduction &gt;15 &amp; =&lt;30 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean last 2 hour SBP reduction &gt;30 &amp; =&lt;45 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean last 2 hour SBP reduction &gt;45 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean last 2 hour DBP reduction =&lt;10 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="77"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean last 2 hour DBP reduction &gt;10 &amp; =&lt;15 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean last 2 hour DBP reduction &gt;15 &amp; =&lt;20 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean last 2 hour DBP reduction &gt;20 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Achieving Mean Seated Systolic and Diastolic Blood Pressure Reductions at Week 3</title>
        <description>number of participants achieving mean seated systolic and diastolic blood pressure reductions of; SBP reduction &lt;= 15 mmHg, SBP reduction &gt; 15 mmHg &amp; &lt;= 30 mmHg, SBP reduction &gt; 30 mmHg &amp; &lt;= 45 mmHg, SBP reduction &gt; 45 mmHg, DBP reduction &lt;= 10 mmHg, DBP reduction &gt; 10 mmHg &amp; &lt;= 15 mmHg, DBP reduction &gt; 15 mmHg &amp; &lt;= 20 mmHg, DBP reduction &gt; 20 mmHg at week 3</description>
        <time_frame>week 0 - week 3</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Aml + Olm + Hctz</title>
            <description>amlodipine + olmesartan medoxomil, if required, + hydrochlorothiazide, if required</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Achieving Mean Seated Systolic and Diastolic Blood Pressure Reductions at Week 3</title>
          <description>number of participants achieving mean seated systolic and diastolic blood pressure reductions of; SBP reduction &lt;= 15 mmHg, SBP reduction &gt; 15 mmHg &amp; &lt;= 30 mmHg, SBP reduction &gt; 30 mmHg &amp; &lt;= 45 mmHg, SBP reduction &gt; 45 mmHg, DBP reduction &lt;= 10 mmHg, DBP reduction &gt; 10 mmHg &amp; &lt;= 15 mmHg, DBP reduction &gt; 15 mmHg &amp; &lt;= 20 mmHg, DBP reduction &gt; 20 mmHg at week 3</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="201"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>mean seated SBP reduction =&lt;15 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="131"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean seated SBP reduction &gt;15 &amp; =&lt;30 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean seated SBP reduction &gt;30 &amp; =&lt;45 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean seated SBP reduction &gt;45 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean seated DBP reduction =&lt;10 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="163"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean seated DBP reduction &gt;10 &amp; =&lt;15 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean seated DBP reduction &gt;15 &amp; =&lt;20 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean seated DBP reduction &gt;20 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Achieving Mean Seated Systolic and Diastolic Blood Pressure Reductions at Week 6</title>
        <description>number of participants achieving mean seated systolic and diastolic blood pressure reductions of; SBP reduction &lt;= 15 mmHg, SBP reduction &gt; 15 mmHg &amp; &lt;= 30 mmHg, SBP reduction &gt; 30 mmHg &amp; &lt;= 45 mmHg, SBP reduction &gt; 45 mmHg, DBP reduction &lt;= 10 mmHg, DBP reduction &gt; 10 mmHg &amp; &lt;= 15 mmHg, DBP reduction &gt; 15 mmHg &amp; &lt;= 20 mmHg, DBP reduction &gt; 20 mmHg at week 6</description>
        <time_frame>week 0 - week 6</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Aml + Olm + Hctz</title>
            <description>amlodipine + olmesartan medoxomil, if required, + hydrochlorothiazide, if required</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Achieving Mean Seated Systolic and Diastolic Blood Pressure Reductions at Week 6</title>
          <description>number of participants achieving mean seated systolic and diastolic blood pressure reductions of; SBP reduction &lt;= 15 mmHg, SBP reduction &gt; 15 mmHg &amp; &lt;= 30 mmHg, SBP reduction &gt; 30 mmHg &amp; &lt;= 45 mmHg, SBP reduction &gt; 45 mmHg, DBP reduction &lt;= 10 mmHg, DBP reduction &gt; 10 mmHg &amp; &lt;= 15 mmHg, DBP reduction &gt; 15 mmHg &amp; &lt;= 20 mmHg, DBP reduction &gt; 20 mmHg at week 6</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="192"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>mean seated SBP reduction =&lt;15 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean seated SBP reduction &gt;15 &amp; =&lt;30 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean seated SBP reduction &gt;30 &amp; =&lt;45 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean seated SBP reduction &gt;45 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean seated DBP reduction =&lt;10 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="120"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean seated DBP reduction &gt;10 &amp; =&lt;15 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean seated DBP reduction &gt;15 &amp; =&lt;20 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean seated DBP reduction &gt;20 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Achieving Mean Seated Systolic and Diastolic Blood Pressure Reductions at Week 9</title>
        <description>number of participants achieving mean seated systolic and diastolic blood pressure reductions of; SBP reduction &lt;= 15 mmHg, SBP reduction &gt; 15 mmHg &amp; &lt;= 30 mmHg, SBP reduction &gt; 30 mmHg &amp; &lt;= 45 mmHg, SBP reduction &gt; 45 mmHg, DBP reduction &lt;= 10 mmHg, DBP reduction &gt; 10 mmHg &amp; &lt;= 15 mmHg, DBP reduction &gt; 15 mmHg &amp; &lt;= 20 mmHg, DBP reduction &gt; 20 mmHg at week 9</description>
        <time_frame>week 0 - week 9</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Aml + Olm + Hctz</title>
            <description>amlodipine + olmesartan medoxomil, if required, + hydrochlorothiazide, if required</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Achieving Mean Seated Systolic and Diastolic Blood Pressure Reductions at Week 9</title>
          <description>number of participants achieving mean seated systolic and diastolic blood pressure reductions of; SBP reduction &lt;= 15 mmHg, SBP reduction &gt; 15 mmHg &amp; &lt;= 30 mmHg, SBP reduction &gt; 30 mmHg &amp; &lt;= 45 mmHg, SBP reduction &gt; 45 mmHg, DBP reduction &lt;= 10 mmHg, DBP reduction &gt; 10 mmHg &amp; &lt;= 15 mmHg, DBP reduction &gt; 15 mmHg &amp; &lt;= 20 mmHg, DBP reduction &gt; 20 mmHg at week 9</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="184"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>mean seated SBP reduction =&lt;15 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean seated SBP reduction &gt;15 &amp; =&lt;30 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean seated SBP reduction &gt;30 &amp; =&lt;45 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean seated SBP reduction &gt;45 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean seated DBP reduction =&lt;10 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean seated DBP reduction &gt;10 &amp; =&lt;15 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean seated DBP reduction &gt;15 &amp; =&lt;20 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean seated DBP reduction &gt;20 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Achieving Mean Seated Systolic and Diastolic Blood Pressure Reductions at Week 12</title>
        <description>number of participants achieving mean seated systolic and diastolic blood pressure reductions of; SBP reduction &lt;= 15 mmHg, SBP reduction &gt; 15 mmHg &amp; &lt;= 30 mmHg, SBP reduction &gt; 30 mmHg &amp; &lt;= 45 mmHg, SBP reduction &gt; 45 mmHg, DBP reduction &lt;= 10 mmHg, DBP reduction &gt; 10 mmHg &amp; &lt;= 15 mmHg, DBP reduction &gt; 15 mmHg &amp; &lt;= 20 mmHg, DBP reduction &gt; 20 mmHg at week 12</description>
        <time_frame>week 0 - week 12</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Aml + Olm + Hctz</title>
            <description>amlodipine + olmesartan medoxomil, if required, + hydrochlorothiazide, if required</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Achieving Mean Seated Systolic and Diastolic Blood Pressure Reductions at Week 12</title>
          <description>number of participants achieving mean seated systolic and diastolic blood pressure reductions of; SBP reduction &lt;= 15 mmHg, SBP reduction &gt; 15 mmHg &amp; &lt;= 30 mmHg, SBP reduction &gt; 30 mmHg &amp; &lt;= 45 mmHg, SBP reduction &gt; 45 mmHg, DBP reduction &lt;= 10 mmHg, DBP reduction &gt; 10 mmHg &amp; &lt;= 15 mmHg, DBP reduction &gt; 15 mmHg &amp; &lt;= 20 mmHg, DBP reduction &gt; 20 mmHg at week 12</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="177"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>mean seated SBP reduction =&lt;15 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean seated SBP reduction &gt;15 &amp; =&lt;30 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean seated SBP reduction &gt;30 &amp; =&lt;45 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean seated SBP reduction &gt;45 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean seated DBP reduction =&lt;10 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean seated DBP reduction &gt;10 &amp; =&lt;15 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean seated DBP reduction &gt;15 &amp; =&lt;20 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean seated DBP reduction &gt;20 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Achieving Mean Seated Systolic and Diastolic Blood Pressure Reductions at Week 15</title>
        <description>number of participants achieving mean seated systolic and diastolic blood pressure reductions of; SBP reduction &lt;= 15 mmHg, SBP reduction &gt; 15 mmHg &amp; &lt;= 30 mmHg, SBP reduction &gt; 30 mmHg &amp; &lt;= 45 mmHg, SBP reduction &gt; 45 mmHg, DBP reduction &lt;= 10 mmHg, DBP reduction &gt; 10 mmHg &amp; &lt;= 15 mmHg, DBP reduction &gt; 15 mmHg &amp; &lt;= 20 mmHg, DBP reduction &gt; 20 mmHg at week 15</description>
        <time_frame>week 0 - week 15</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Aml + Olm + Hctz</title>
            <description>amlodipine + olmesartan medoxomil, if required, + hydrochlorothiazide, if required</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Achieving Mean Seated Systolic and Diastolic Blood Pressure Reductions at Week 15</title>
          <description>number of participants achieving mean seated systolic and diastolic blood pressure reductions of; SBP reduction &lt;= 15 mmHg, SBP reduction &gt; 15 mmHg &amp; &lt;= 30 mmHg, SBP reduction &gt; 30 mmHg &amp; &lt;= 45 mmHg, SBP reduction &gt; 45 mmHg, DBP reduction &lt;= 10 mmHg, DBP reduction &gt; 10 mmHg &amp; &lt;= 15 mmHg, DBP reduction &gt; 15 mmHg &amp; &lt;= 20 mmHg, DBP reduction &gt; 20 mmHg at week 15</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="172"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>mean seated SBP reduction =&lt;15 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean seated SBP reduction &gt;15 &amp; =&lt;30 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean seated SBP reduction &gt;30 &amp; =&lt;45 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean seated SBP reduction &gt;45 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean seated DBP reduction =&lt;10 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean seated DBP reduction &gt;10 &amp; =&lt;15 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean seated DBP reduction &gt;15 &amp; =&lt;20 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean seated DBP reduction &gt;20 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Achieving Mean Seated Systolic and Diastolic Blood Pressure Reductions at Week 18</title>
        <description>number of participants achieving mean seated systolic and diastolic blood pressure reductions of; SBP reduction &lt;= 15 mmHg, SBP reduction &gt; 15 mmHg &amp; &lt;= 30 mmHg, SBP reduction &gt; 30 mmHg &amp; &lt;= 45 mmHg, SBP reduction &gt; 45 mmHg, DBP reduction &lt;= 10 mmHg, DBP reduction &gt; 10 mmHg &amp; &lt;= 15 mmHg, DBP reduction &gt; 15 mmHg &amp; &lt;= 20 mmHg, DBP reduction &gt; 20 mmHg at week 18</description>
        <time_frame>week 0 - week 18</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Aml + Olm + Hctz</title>
            <description>amlodipine + olmesartan medoxomil, if required, + hydrochlorothiazide, if required</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Achieving Mean Seated Systolic and Diastolic Blood Pressure Reductions at Week 18</title>
          <description>number of participants achieving mean seated systolic and diastolic blood pressure reductions of; SBP reduction &lt;= 15 mmHg, SBP reduction &gt; 15 mmHg &amp; &lt;= 30 mmHg, SBP reduction &gt; 30 mmHg &amp; &lt;= 45 mmHg, SBP reduction &gt; 45 mmHg, DBP reduction &lt;= 10 mmHg, DBP reduction &gt; 10 mmHg &amp; &lt;= 15 mmHg, DBP reduction &gt; 15 mmHg &amp; &lt;= 20 mmHg, DBP reduction &gt; 20 mmHg at week 18</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="164"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>mean seated SBP reduction =&lt;15 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean seated SBP reduction &gt;15 &amp; =&lt;30 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean seated SBP reduction &gt;30 &amp; =&lt;45 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean seated SBP reduction &gt;45 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean seated DBP reduction =&lt;10 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean seated DBP reduction &gt;10 &amp; =&lt;15 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean seated DBP reduction &gt;15 &amp; =&lt;20 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean seated DBP reduction &gt;20 mm Hg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>ALL - Aml + Olm + Hctz</title>
          <description>Summary of ALL participants receiving amlodipine + olmesartan medoxomil, if required, + hydrochlorothiazide, if required</description>
        </group>
        <group group_id="E2">
          <title>Start - Amlodipine 5 mg</title>
          <description>All participants started trial on Amlodipine 5 mg.</description>
        </group>
        <group group_id="E3">
          <title>Titration 1 - Amlodipine 5 mg / Olmesartan 20 mg</title>
          <description>Participants not meeting blood pressure (BP) goals on previous regimen were titrated to this regimen.</description>
        </group>
        <group group_id="E4">
          <title>Titration 2 - Amlodipine 5 mg / Olmesartan 40 mg</title>
          <description>Participants not meeting blood pressure (BP) goals on previous regimen were titrated to this regimen.</description>
        </group>
        <group group_id="E5">
          <title>Titration 3 - Amlodipine 10 mg / Olmesartan 40 mg</title>
          <description>Participants not meeting blood pressure (BP) goals on previous regimen were titrated to this regimen.</description>
        </group>
        <group group_id="E6">
          <title>Titration 4 Amlodipine 10 mg / Olmesartan 40 mg / HCTZ 12.5 mg</title>
          <description>Participants not meeting blood pressure (BP) goals on previous regimen were titrated to this regimen.</description>
        </group>
        <group group_id="E7">
          <title>Titration 5 - Amlodipine 10 mg / Olmesartan 40 mg / HCTZ 25 mg</title>
          <description>Participants not meeting blood pressure (BP) goals on previous regimen were titrated to this regimen.</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA 11.0</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="207"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="167"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="146"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="101"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>pneumonia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="207"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="167"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="146"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="101"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>hyperkalaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="207"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="167"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="146"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="101"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title vocab="MedDRA (11.0)">presyncope</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="207"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="167"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="146"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="101"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title vocab="MedDRA (11.0)">chronic obstructive pulmonary disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="207"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="177"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="167"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="146"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="101"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>2</frequency_threshold>
        <default_vocab>MedDRA (11.0)</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="80" subjects_at_risk="207"/>
                <counts group_id="E2" subjects_affected="16" subjects_at_risk="207"/>
                <counts group_id="E3" subjects_affected="15" subjects_at_risk="195"/>
                <counts group_id="E4" subjects_affected="10" subjects_at_risk="177"/>
                <counts group_id="E5" subjects_affected="21" subjects_at_risk="167"/>
                <counts group_id="E6" subjects_affected="14" subjects_at_risk="146"/>
                <counts group_id="E7" subjects_affected="4" subjects_at_risk="101"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>anaemia</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="207"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E5" events="4" subjects_affected="4" subjects_at_risk="167"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="146"/>
                <counts group_id="E7" events="2" subjects_affected="2" subjects_at_risk="101"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>oedema peripheral</sub_title>
                <counts group_id="E1" events="20" subjects_affected="20" subjects_at_risk="207"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="207"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="195"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="177"/>
                <counts group_id="E5" events="7" subjects_affected="7" subjects_at_risk="167"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="146"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="101"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>upper respiratory tract infection</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="207"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="195"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="177"/>
                <counts group_id="E5" events="3" subjects_affected="3" subjects_at_risk="167"/>
                <counts group_id="E6" events="3" subjects_affected="3" subjects_at_risk="146"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="101"/>
              </event>
              <event>
                <sub_title>bronchitis</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="207"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="207"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="195"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="167"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="146"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="101"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>pain in extremity</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="207"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="207"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="195"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="177"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="167"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="146"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="101"/>
              </event>
              <event>
                <sub_title>arthralgia</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="207"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="207"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="195"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="167"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="146"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="101"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>dizziness</sub_title>
                <counts group_id="E1" events="12" subjects_affected="12" subjects_at_risk="207"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="207"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="195"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="177"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="167"/>
                <counts group_id="E6" events="5" subjects_affected="5" subjects_at_risk="146"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="101"/>
              </event>
              <event>
                <sub_title>headache</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="207"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="207"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E5" events="2" subjects_affected="2" subjects_at_risk="167"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="146"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="101"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>cough</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="207"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="195"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="177"/>
                <counts group_id="E5" events="2" subjects_affected="2" subjects_at_risk="167"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="146"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="101"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>hypotension</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="207"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="195"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="167"/>
                <counts group_id="E6" events="2" subjects_affected="2" subjects_at_risk="146"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="101"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Sponsor reflects the following restrictive language in the Clinical Study Agreements: &quot;If identified by Daiichi Sankyo Inc. (DSI), any of DSI's confidential information as defined herein shall be deleted. Nothing in this publication section shall be taken as giving DSI any right of editorial control over any publication prepared by the Study Site.&quot;</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>James McCarthy</name_or_title>
      <organization>Daiichi Sankyo</organization>
      <phone>732-590-3430</phone>
      <email>jmccarthy@dsi.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

